Increasing Prevalence of Cardiovascular Diseases & Growing Awareness of Compression Therapy

 

The India Static Compression Therapy Market is estimated to be valued at US$ 181.1 Mn in 2022 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Static compression therapy includes compression garments and devices that are used to treat chronic venous insufficiency, deep vein thrombosis, lymphedema, and other conditions. Compression bandages, stockings and sleeves are commonly used static compression products that apply graduated compression around a limb or other body part to help push blood and lymph fluid back to the heart and Prevent fluid buildup. They are widely used in hospitals and clinics as well as prescribed for self-care.

Market Dynamics:
The India static compression therapy market is driven by the increasing prevalence of cardiovascular diseases such as deep vein thrombosis, varicose veins and lymphedema which require compression therapies. According to the Cardiological Society of India, cardiovascular diseases accounted for 28% of total deaths in India in 2020, with numbers expected to rise further. Growing awareness among people about benefits of compression garments in preventing and managing such conditions is also fueling market growth. Furthermore, presence of leading players and availability of various compression products at affordable prices are boosting market expansion. However, lack of reimbursement policies for compression therapies in India limits market potential.

SWOT Analysis
Strength: The India static compression therapy market has a large pool of patients suffering from chronic venous diseases, deep vein thrombosis and lymphedema. There is a growing awareness among people regarding benefits of compression therapy. Many hospitals and physical therapy centers provide these therapies.
Weakness: High cost of compression therapy products is a major restraint. Lack of reimbursement policies further increases patient's out-of-pocket expenditure. Low compliance to compression garments during course of therapy hampers full recovery.
Opportunity: Increasing incidences of sports injuries and accidents provides growth opportunities. Growing medical tourism industry also supports market growth. Market players can focus on developing low cost products to penetrate rural areas.
Threats: Alternative treatment therapies like medication, surgical procedures, physical exercises possess threat to static compression products. Unorganized players providing low quality products at lower prices can negatively impact established brands.

Key Takeaways

The Global India Static Compression Therapy Market Size is expected to witness high growth, exhibiting CAGR of 7.4% over the forecast period, due to increasing incidences of venous leg ulcers, deep vein thrombosis and sports injuries. The North Indian region currently dominates the market due to presence of key players and advanced healthcare facilities.

Regional analysis - North India is expected to maintains its dominance during the forecast period, growing at a CAGR of 8.1%. This is attributed to increasing healthcare expenditure and presence of major market players in states like Delhi, Maharashtra and Gujarat. West India is the fastest growing region due to growing medical tourism and awareness.

Key players - Key players operating in the India static compression therapy market are 3M, BSN Medical, Sigvaris AG, Cardinal Health, Medi GmbH & Co, ArjoHuntleigh Healthcare India, Bio Compression Systems Inc, Zimmer Biomet India, and Vissco Healthcare. These players are focusing on new product launches and geographical expansions to strengthen their market presence.

Read more: https://www.rapidwebwire.com/market-prospects-of-india-static-compression-therapy-looks-promising/ 

Comments

Popular posts from this blog

Vegan Yogurt Market is Poised for Growth Driven by Rising Health Consciousness

Hypoglycemic Drugs Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes in the Geriatric Population

Clinical Trials Rising with Digital Technologies Adoption